December 28, 2025 12:47 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
CBI moves Supreme Court challenging Kuldeep Sengar's relief in Unnao rape case | Music under attack: Islamist mob attacks James concert with bricks, stones in Bangladesh, dozens hurt | Christmas vandalism sparks mass arrests in Raipur; Assam acts too with crackdown on 'religious intolerance' | BJP's VV Rajesh becomes Thiruvananthapuram Mayor after party topples Left's 45-year-rule in city corporation | ‘I can’t bear the pain’: Indian-origin father of three dies after 8-hour hospital wait in Canada hospital | Janhvi Kapoor, Kajal Aggarwal, Jaya Prada slam brutal lynching in Bangladesh, call out ‘selective outrage’ | Tarique Rahman returns to Bangladesh after 17 years | Shocking killing inside AMU campus: teacher shot dead during evening walk | Horror on Karnataka highway: sleeper bus bursts into flames after truck crash, 9 killed | PM Modi attends Christmas service at Delhi church, sends message of love and compassion
Sinopharm
Image Credit: wikipedia.org

China's Sinopharm Covid-19 vaccine gets WHO's nod for emergency use

| @indiablooms | May 08, 2021, at 04:50 am

Geneva/IBNS: The World Health Organisation (WHO) on Friday gave emergency use approval for a coronavirus vaccine made by China's state-owned drug manufacturer Sinopharm, said a Reuters report.

The vaccine is one of the two shots made by China and has been exported to several countries and given to millions of people in China, according to the report.

It is also the first vaccine made by a non-western country to get the UN health body's approval and also the first Chinese vaccine to get its nod for any infectious disease, the report said.

This draws significance as WHO's approval is a benchmark of safety and efficacy of a product for countries. It also means that the Chinese vaccine can now be included in COVAX, the programme to make available coronavirus vaccine to poor countries across the globe.

Johnson & Johnson, AsyraZeneca, Pfizer-BioNTech and Moderna have so far received approval for emergency use from WHO.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.